Sector: Pharmaceuticals & Biotechnology

Mid Cap

Corona Remedies Share Price

CORONA

₹2,158.70

16.10(0.75%)

24th Aug 2026 | 11:38 AM

NSE : CORONA

Open Free Demat Account

Corona Remedies Performance

Price Movement

₹2158.70

₹2130.10

₹2161.80

↘ Today's Low↗ Today's High

1 Year Performance

₹2158.70

₹1336.60

₹2270.10

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,161.80

Low₹2,130.10

Open at₹2,144.00

Prev Close₹2,142.60

Volumes5.30 K

Avg Price₹2,150.33

Lower Circuit₹1,714.10

Upper Circuit₹2,571.10

Historical Performance

3M High₹2,270.10

3M Low₹1,656.30

1 Yr High₹2,270.10

1 Yr Low₹1,336.60

3 Yr High₹2,270.10

3 Yr Low₹1,336.60

5 Yr High₹2,270.10

5 Yr Low₹1,336.60

Summary

As of 24-08-2026 12:01, Corona Remedies Ltd. share price today is ₹0, with a change of ₹-2142.60 (-100.00%) from the previous close of ₹2142.6. The stock opened at ₹2144 and traded between ₹2130.1 and ₹2161.8, with a total traded volume of 5297 shares. The company has a market capitalization of ₹12974.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2270.1 and ₹1336.6, respectively.

Corona Remedies Ltd. valuation metrics include a P/E ratio of 65.2, EPS of ₹30.27, and book value of ₹17.40. Profitability indicators show ROE of 24.78% along with a dividend yield of 0.5%. Corona Remedies Ltd. has reported revenue of ₹1479.07 Cr and net profit of ₹199.03 Cr.

Corona Remedies Ltd. technical indicators include Day RSI at 57.33, Day MFI at 81.24, Day ADX at 41.86. Additional indicators include Commodity Channel Index (CCI) at 63 and Williams %R at -63.25. Momentum indicators show Day MACD at 31.28, Day MACD Signal Line at 36.15, DayATR at 67.67. Rate of Change indicators for Corona Remedies Ltd. include ROC125 at 33.16 and ROC21 at 1.49.

Exponential moving averages include EMA5 at ₹2118.4, EMA10 at ₹2111.4, EMA12 at ₹2108.3, EMA20 at ₹2092.6, EMA26 at ₹2077, EMA50 at ₹2004.7, EMA100 at ₹1872.6. Simple moving averages include SMA5 at ₹2120.8, SMA10 at ₹2102.7, SMA20 at ₹2099.9, SMA30 at ₹2084.5, SMA50 at ₹2003.5, SMA100 at ₹1834, SMA150 at ₹1734.8.

Support levels for Corona Remedies are placed at First Support ₹2098.83, Second Support ₹2076.27, Third Support ₹2045.43. Resistance levels are seen at First Resistance ₹2152.23, Second Resistance ₹2183.07, Third Resistance ₹2205.63. Corona Remedies Ltd. shareholding pattern shows promoter holding at 69%, FII holding at 3.63%, DII holding at 0%, public holding at 14.47%.

Corona Remedies Fundamentals

Market Cap

High in industry

12,974.50 Cr.

PE Ratio (TTM)

High in industry

65.20

Dividend Yield

Below industry Median

0.50

Net Profit TTM

199.03

Net Profit Growth

199.03

PEG Ratio

ROE

0.6% incr over last year

24.78

Operating Revenue TTM

1,479.07

Operating Revenue Growth

Book Value

High in industry

17.40

MFI

MFI strongly Overbought

81.24

RSI

RSI is mid-range

57.33

EPS (TTM)

30.27

Debt to Equity

0.19

Face Value

Operating Profit Margin Qtr.

20.75

Operating Profit Qtr.

93.13

Net Profit Qtr.

60.11

Operating Revenue Qtr.

422.43

PB Ratio

17.40

Corona Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	422.43	353.09	342.42	361.13	346.54
Operating Expense	329.30	291.07	259.26	282.66	276.76
Operating Profit	93.13	62.02	83.16	78.47	69.78
Depreciation	13.24	10.29	9.45	9.20	8.92
Interest	2.69	1.38	1.66	1.93	1.99
Tax	20.25	9.41	13.94	17.46	14.49
Net Profit	60.10	45.05	41.25	52.15	46.40

Corona Remedies Technicals

Corona Remedies Ltd. EMA & SMA

₹2158.70

39.30 (1.85%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2118.4

Day EMA10 ₹2111.4

Day EMA12 ₹2108.3

Day EMA20 ₹2092.6

Day EMA26 ₹2077

Day EMA50 ₹2004.7

Day EMA100 ₹1872.6

Corona Remedies Support and Resistance

Resistance

First Resistance₹2152.23

Second Resistance₹2183.07

Third Resistance₹2205.63

Support

First Support₹2098.83

Second Support₹2076.27

Third Support₹2045.43

Technical Indicators

Day RSI57.33

Day MFI81.24

Day ADX41.86

Day Commodity Channel Index63.00

William-63.25

Day MACD31.28

Day MACD Signal Line36.15

Day ATR67.67

Day ROC12533.16

Day ROC211.49

Corona Remedies Shareholding Pattern

Held By	Dec 2025	Mar 2026	Jun 2026
Promoter	69	69	69
FII	1.8	2.2	3.6
DII	6.8	7.1	12.9
Public	22.4	21.8	14.5

Corona Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	45.93 K	62.65 K	73.32%
Week	18.67 K	29.55 K	63.20%
1 Month	23.55 K	49.69 K	47.40%
6 Month	23.48 K	48.21 K	48.71%

Corona Remedies SWOT Analysis

Strengths24

Weakness5

Opportunity3

Threats1

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

High Volume, High Gain

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Corona Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Jun, 2026	10	FINAL	19 Jun, 2026	Equity Share

Corona Remedies Stock Comparison

Financials	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹1,125.85	₹1,566	₹1,527	₹4,190.20	₹774.50
% Change	1.26%	3.48%	-0.52%	-0.76%	3.27%
Revenue TTM (₹ Cr)	₹675.61	₹691.72	₹1,543.34	₹949.80	₹4,501.61
Net Profit TTM (₹ Cr)	₹182.64	₹126.37	₹-48.62	₹266	₹291.72
PE TTM	71.50	56.50	-358.60	36.60	40.60
1 Year Return	95.01	121.72	-17.12	-19	57.13
ROCE	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 1078.70

-0.90%

BLUEJET

Blue Jet Healthcare Ltd

₹ 605.00

+1.48%

CONCORDBIO

Concord Biotech Ltd.

₹ 1536.20

-2.23%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 843.00

+3.21%

SUPRIYA

Supriya Lifescience Ltd.

₹ 803.80

-0.20%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1346.60

-0.32%

COHANCE

Cohance Lifesciences Ltd.

₹ 452.20

-2.33%

ERIS

Eris Lifesciences Ltd.

₹ 1313.80

-1.08%

SYNGENE

Syngene International Ltd.

₹ 401.30

-1.46%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 815.00

-0.82%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 197.07

+0.18%

STAR

Strides Pharma Science Ltd.

₹ 981.30

-0.50%

FDC

FDC Ltd.

₹ 348.40

-0.06%

SHILPAMED

Shilpa Medicare Ltd.

₹ 862.35

+5.82%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 891.55

+1.27%

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2500.00

-2.37%

MARKSANS

Marksans Pharma Ltd.

₹ 322.60

+0.40%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1020.50

+1.84%

VIYASH

Viyash Scientific Ltd.

₹ 268.60

-2.66%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7265.00

-2.03%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 570.50

-1.49%

SANOFI

Sanofi India Ltd.

₹ 3315.00

-1.13%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.40

+0.41%

PGHL

Procter & Gamble Health Ltd.

₹ 5869.00

+0.69%

FAQ's on CORONA

What is the current share price of Corona Remedies Ltd.?

As of 19 August 2026 at 10:01 AM, the share price for Corona Remedies Ltd. is ₹ 2158.7 on the NSE and ₹ 2156.65 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Corona Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 19 August 2026, the market cap for Corona Remedies Ltd. is approximately ₹ 12974.5 Cr.

What are the PE and PB ratios for Corona Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Corona Remedies Ltd. is 65.2, and the Price-to-Book (PB) ratio is 17.4.

What is the 52-Week High and Low for Corona Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Corona Remedies Ltd. shares was ₹ 2270.1, and the lowest price was ₹ 1336.6.

What is the current dividend yield for Corona Remedies Ltd.?

As of 19 August 2026, the dividend yield for Corona Remedies Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Corona Remedies Ltd.?

Significant shareholdings in Corona Remedies Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Corona Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Corona Remedies Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Corona Remedies Ltd.?

Corona Remedies Ltd. last declared a FINAL dividend of ₹ 10 per share for the financial period ending 2026. The record date was set as 2026-06-19, and the payment was/is scheduled around 2026-06-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy